ArticleTherapeutic advances in hematology2026

Effectiveness of caplacizumab in the first-line treatment for acquired thrombotic thrombocytopenic purpura: single center experience.

Kristina Maria Belakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.